A detailed history of Price T Rowe Associates Inc transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 288,900 shares of SENS stock, worth $89,559. This represents 0.0% of its overall portfolio holdings.

Number of Shares
288,900
Previous 288,900 -0.0%
Holding current value
$89,559
Previous $113,000 9.73%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.37 - $0.52 $28,971 - $40,716
-78,300 Reduced 21.32%
288,900 $113,000
Q1 2024

May 15, 2024

BUY
$0.5 - $0.73 $25,500 - $37,230
51,000 Added 16.13%
367,200 $196,000
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.7 $47,184 - $68,810
98,300 Added 45.11%
316,200 $181,000
Q2 2023

Aug 14, 2023

SELL
$0.55 - $0.89 $84,518 - $136,766
-153,670 Reduced 41.36%
217,900 $167,000
Q1 2023

May 15, 2023

SELL
$0.68 - $1.25 $795 - $1,462
-1,170 Reduced 0.31%
371,570 $264,000
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.34 $33,887 - $47,300
35,299 Added 10.46%
372,740 $384,000
Q3 2022

Nov 14, 2022

BUY
$1.02 - $2.23 $28,605 - $62,540
28,045 Added 9.06%
337,441 $446,000
Q2 2022

Aug 15, 2022

BUY
$0.94 - $1.94 $58,523 - $120,782
62,259 Added 25.19%
309,396 $319,000
Q1 2022

May 16, 2022

SELL
$1.54 - $3.71 $30,970 - $74,611
-20,111 Reduced 7.53%
247,137 $487,000
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $146,574 - $222,134
56,812 Added 27.0%
267,248 $714,000
Q3 2021

Nov 15, 2021

BUY
$2.77 - $4.05 $152,197 - $222,527
54,945 Added 35.34%
210,436 $713,000
Q2 2021

Aug 16, 2021

BUY
$1.71 - $4.14 $131,996 - $319,570
77,191 Added 98.58%
155,491 $597,000
Q1 2021

May 17, 2021

SELL
$0.85 - $5.27 $57,824 - $358,512
-68,029 Reduced 46.49%
78,300 $207,000
Q4 2020

Feb 16, 2021

BUY
$0.36 - $0.95 $52,678 - $139,012
146,329 New
146,329 $128,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $144M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.